Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
genentech
7
×
indiana blog main
indiana top stories
life sciences
7
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
7
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
bristol-myers squibb
eli lilly
pfizer
cancer
clinical trials
fda
johnson & johnson
deals
glaxosmithkline
ipo
president trump
What
bio
roundup
drug
news
approved
cancer
companies
drugs
fda
group
known
medical
pharmaceutical
adu
alzheimer’s
annual
appetite
august
beats
bids
biogen
biopharma
biotech
black
bread
breast
busy
butter
buyout
cancer's
cash
clinical
complicated
conference
congress
congressional
crispr
data
days
decisions
Language
unset
Current search:
genentech
×
" life sciences "
×
" seattle blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front